1. "2014"
Formats
  1. Journal Article (2603)
  2. Meeting Abstract (1417)
  3. Book Section (235)
  4. Conference Paper (23)
  5. Book Whole (16)
  6. Review (3)
Groups
  1. Department of Medicine (1584)
  2. GSK Faculty (1082)
  3. Surgery (895)
  4. Solid Tumor Oncology Division (840)
  5. Center for Hematologic Malignancies (703)
  6. Sloan Kettering Institute Faculty (672)

More Groups

People
  1. Jedd Wolchok (71)
  2. Sergio Giralt (71)
  3. Ross Levine (69)
  4. Martin Tallman (62)
  5. Michael Berger (59)
  6. Mithat Gonen (55)

More People

Years
  1. 2014 (4297)
Publications
  1. Journal of Clinical Oncology (420)
  2. Blood (228)
  3. International Journal of Radiation Oncology, Biology, Physics (131)
  4. Cancer Research (104)
  5. Modern Pathology (89)
  6. Laboratory Investigation (82)

More Publications

Publishers
  1. Elsevier Inc. (495)
  2. American Society of Clinical Oncology (446)
  3. Springer (318)
  4. Elsevier Science, Inc. (246)
  5. Nature Publishing Group (242)
  6. American Society of Hematology (230)

More Publishers

Results (4297)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cutaneous basal cell carcinomas and squamous cell carcinomas frequently harbor TERT promoter mutations
    Meeting Abstract

    Murali, R.; Griewank, K. G.; Schilling, B.; Schimming, T.; Moller, I.; Moll, I.; Schwamborn, M.; Sucker, A.; Zimmer, L.; Schadendorf, D.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • NAB2-STAT6 fusion and STAT6 immunohistochemistry help differentiating sinonasal hemangiopericytoma-like tumors from solitary fibrous tumor
    Meeting Abstract

    Mosquera, J. M.; Chen, C. L.; Scognamiglio, T.; Chua, J. P.; Basha, B. M.; Chinnaiyan, A. M.; Jungbluth, A.; Antonescu, C. R.
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • Pathology reporting v. research review for prostate cancer gleason scoring: Insights from tumor mapping and volumetric studies
    Meeting Abstract

    Mehta, V.; Chang, J.; Matsumoto, K.; Al-Ahmadie, H. A.; Chen, Y. B.; Gopalan, A.; Tickoo, S. K.; Reuter, V. E.; Fine, S. W.
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • The genomic landscape of adenoid cystic carcinoma of the breast
    Meeting Abstract

    Martelotto, L. G.; Ng, C. K.; Lim, R.; Piscuoglio, S.; Natrajan, R.; Wetterskog, D.; Colombo, P. E.; Reis, J. S.; Vincent-Salomon, A.; Weigelt, B.
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • Exploring mutational profiles in two major histologic subtypes of ampullary carcinoma by targeted cancer gene sequencing
    Meeting Abstract

    Liu, W.; Shia, J.; Won, H.; Berger, M.; Klimstra, D.
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • Next generation sequencing in effusion fluids from patients with ovarian serous carcinoma. A comparison with TCGA findings
    Meeting Abstract

    Lin, O.; Brannon, A. R.; Levine, D. A.; Arcila, M. E.; Scott, S. N.; Edelweiss, M.; Berger, M. F.
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • Array CGH analysis of 64 penile squamous cell carcinomas: Correlation with pathological and aetiological factors
    Meeting Abstract

    La-Touche, S.; Lemetre, C.; Stankiewicz, E.; Ng, C. K.; Weigelt, B.; Lambros, M.; Rajab, R.; Tinwell, B.; Corbishley, C.; Watkin, N.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • ACTH-secreting pancreatic neuroendocrine tumors associated with Cushing's syndrome: Clinico-pathologic study of 10 cases
    Meeting Abstract

    La Rosa, S.; Albarello, L.; Vanoli, A.; Milione, M.; Basturk, O.; Klimstra, D. S.; Watchtel, A.; Capella, C.; Davi, M. V.; Scarpa, A.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • mTOR pathway activation characterizes a subset of unclassified renal cell carcinoma: Immunohistochemical, molecular and histologic analysis
    Meeting Abstract

    Kong, M. X.; Brannon, A. R. R.; Won, H.; Gandhi, A.; Al-Ahmadie, H. A.; Fine, S. W.; Gopalan, A.; Russo, P.; Berger, M. F.; Tickoo, S. K.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • A recurrent point mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma
    Meeting Abstract

    Kohsaka, S.; Shukla, N.; Ameur, N.; Lim, D. ; Viale, A.; Socci, N.; Qin, L. X.; Sciot, R.; Bridge, J.; Singer, S.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save